![](/img/cover-not-exists.png)
Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
Eric Esrailian, Eugene R. Pantangco, Namgyal L. Kyulo, Ke-Qin Hu, Bruce A. RunyonVolume:
52
Language:
english
Pages:
7
DOI:
10.1007/s10620-006-9312-0
Date:
March, 2007
File:
PDF, 194 KB
english, 2007